https://risenanooptics.com/rise-pr-1/2025-09-18T10:15:37+00:00https://risenanooptics.com/rise-pr-2/2025-09-18T10:13:42+00:00https://risenanooptics.com/rise-pr-3/2025-09-18T10:12:55+00:00https://risenanooptics.com/rise-health-nano-optics-granted-third-u-s-patent-for-breakthrough-nano-optic-technology-advancing-preventative-vision-care/2025-11-11T11:57:41+00:00https://risenanooptics.com/rise-nano-optics-receives-final-receipt-for-prospectus-and-closes-rto-transaction/2026-03-09T15:05:04+00:00https://risenanooptics.com/rise-nano-optics-to-commence-trading-on-the-canadian-securities-exchange-under-the-symbol-eye-today-march-12-2026/2026-03-22T14:49:33+00:00https://risenanooptics.com/rise-nano-optics-appoints-erik-ritchie-as-chief-commercial-officer-to-lead-north-american-commercialization-strategy/2026-03-22T14:51:44+00:00https://risenanooptics.com/rise-nano-optics-appoints-erik-ritchie-as-chief-commercial-officer-to-lead-north-american-commercialization-strategy-2/2026-03-24T18:25:27+00:00https://risenanooptics.com/rise-nano-optics-announces-strategic-partnership-with-sierra-optical-lab-to-produce-and-commercialize-spectraguard-lenses-in-the-united-states/2026-04-21T17:44:01+00:00